Lupin receives USFDA approval for generic Liraglutide Injection and Glucagon, expanding access to diabetes treatments.

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. A new stem cell ...

Reversing hypoglycemia After implanting the device in diabetic mice, the researchers used it to trigger glucagon release as the animals' blood sugar levels were dropping.

Hypoglycemia occurs when blood sugar levels drop below 70 milligrams per deciliter (mg/dl). Severe hypoglycemia can be life-threatening if a person does not receive treatment. Treatments focus on ...

MIT researchers develop implantable device to prevent hypoglycemia in diabetes patients MIT scientists create a miniaturized device to help manage diabetes-related emergencies automatically ...

Reversing hypoglycemia After implanting the device in diabetic mice, the researchers used it to trigger glucagon release as the animals’ blood sugar levels were dropping.

Hypoglycemia, or low blood sugar, is a potentially dangerous condition that’s most common in people with diabetes. Learn more here.

Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Glucagon-like peptide 1 (GLP-1) receptor agonists are a favored treatment for type-2 diabetes but ...

Senate Minority Leader Chuck Schumer, 74, was at the Senate gym when he became lightheaded, his spokesperson said.